Novel diagnostic and therapeutic approaches to the diabetic retinopathy

European Review for Medical and Pharmacological Sciences

Volumn 5, Issue 5-6, 2002, Pages 155-166

  Giusti, C ^a  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

Author keywords

Diabetes; Diabetic retinopathy; Retina

Indexed keywords

ACETAZOLAMIDE; ALDOSE REDUCTASE INHIBITOR; ALPHA TOCOPHEROL; ANTIHISTAMINIC AGENT; CARBONATE DEHYDRATASE INHIBITOR; DEFIBROTIDE; GROWTH HORMONE; HEMOGLOBIN A1C; INSULIN; METFORMIN; OCTREOTIDE; RECOMBINANT SOMATOMEDIN C; SOMATOMEDIN C; SOMATOSTATIN DERIVATIVE; SULFONYLUREA;

CLINICAL PROTOCOL; COLOR VISION TEST; COMPUTER ASSISTED PERIMETRY; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ELECTRORETINOGRAPHY; EVOKED VISUAL RESPONSE; HEALTH CARE QUALITY; HUMAN; INDUSTRIALIZATION; LASER COAGULATION; LENSECTOMY; OPHTHALMOLOGY; OPTICAL COHERENCE TOMOGRAPHY; OSCILLATORY POTENTIAL; PRACTICE GUIDELINE; RETINA FLUORESCEIN ANGIOGRAPHY; REVIEW; SCREENING TEST; SIDE EFFECT; TREATMENT PLANNING; VISUAL IMPAIRMENT; VISUAL SYSTEM EXAMINATION; VITRECTOMY;

DIABETES MELLITUS; DIABETIC RETINOPATHY; HUMANS; LASER SURGERY;

EID: 0036335872     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (90)

1. Diabetic retinopathy. Screening and prevention of blindness. A doctoral thesis
2. The 14-year incidence of visual loss in a diabetic population
3. A screening approach to the surveillance of patients with diabetes for the presence of vision-threatening retinopathy
4. Retinopathy in juvenile diabetes: A 10-year (1990-2000) review
5. Systemic considerations in the management of diabetic retinopathy
6. Early photocoagulation for diabetic retinopathy. ETDRS report no. 8 & 9
7. Diabetic retinopathy: Medico-legal implications and statistical evaluation on 341 type 1 and type 2 diabetic patients
8. Principles and practice of ophthalmology
9. Report 7. A modification of the Airlie House classification of diabetic retinopathy
10. Grading diabetic retinopathy from stereoscopic color fundus photographs - An exyension of the modified Airlie House classification. ET-DRS report number 10
11. An alternative method of grading diabetic retinopathy
12. A quantitative system to evaluate diabetic retinopathy from fundus photographs
13. Classification of diabetic retinopathy from fluorescein angiograms. ETDRS report number 11
14. Diabetic retinopathy screening is a requirement. Don't wait until vision becomes impared
15. Diabetic retinopathy: Technical review
16. Diabetic retinopathy: Position Statement
17. Prevalence of diabetic retinopathy in children and adolescents with IDDM. A population-based multicentre study
18. Diabetes complication screening in 937 children and adolescents
19. Microaneurysms in the development of diabetic retinopathy (UKPDS 42)
20. Grading diabetic retinopathy from stereoscopic color fundus photographs - An extension of the modified Airlie House classification. E - DRS report number 10
21. Color photography vs fluorescein angiography in the detection of diabetic retinopathy in the diabetes control and complications trial
22. Visual fields at different stages of diabetic retinopathy
23. Blue-on-yellow and achromatic perimetry in diabetic children without retinopathy
24. Entoptic perimetry screening for central diabetic scotomas and macular edema
25. Ocular haemodynamics and colour contrast sensitivity in patients with type 1 diabetes
26. Impaired color vision associated with diabetic retinopathy: Early Treatment Diabetic Retinopathy Study report n° 15
27. Lanthony 15-Hue desaturated test for screening of early colour vision defects in uncomplicated juvenile diabetes
28. Visual evoked potentials after photostress in newly diagnosed insulindependent diabetic patients
29. Multifocal oscillatory potentials in type 1 diabetes without retinopathy
30. Morphological and functional analyses of diabetic macular edema by optical coherence tomography and multifocal electroretinograms
31. Detection of inner retina dysfunction by steady-state focal electroretinogram pattern and flicker in early IDDM
32. Visual electrophysiological responses in persons with type 1 diabetes
33. Presence and further development of retinal dysfunction after 3-year follow up in IDDM patients without angiographically documented vasculopathy
34. The electroretinogram in diabetic retinopathy
35. Predicting progression to severe proliferative diabetic retinopathy
36. Iris fluorescein angiography in clinical practice
37. Colour slides or digital photography in diabetes screening - A comparison
38. Stereo nonmydriatic digital-video color retinal imaging compared with Early Treatment Diabetic Retinopathy Study seven standard field 35-mm stereo color photos for determining level of diabetic retinopathy
39. Is acetazolamide effective in the treatment of diabetic macular edema? A pilot study
40. Reproducibility of retinal mapping using optical coherence tomography
41. Optical coherence tomography of tractional macular elevations in eyes with proliferative diabetic retinopathy
42. Quantitative assessment of retinal thickness in diabetic patients with and without clinically significant macular edema using optical coherence tomography
43. Improvement of reproducibility of macular volume measurements using the Heidelberg retinal tomograph
44. Sensitivity and specificity of a new scoring system for diabetic macular edema detection using a confocal laser imaging system
45. Quantitative assessment of macular thickness in normal subjects and patients with diabetic retinopathy by scanning retinal thickness analyser
46. Telemedicine and ophthalmology
47. Teleophthalmology: The use of real-time telementoring to remove an orbital tumor
48. Telemedicine screening of glaucoma
49. Identification of diabetic retinopathy by stereoscopic digital imaging via teleophthalmology: A comparison to slide film
50. Screening for diabetic retinopathy in rural areas: The potential of telemedicine
51. Barriers to prevention of vision loss caused by diabetic retinopathy
52. Discordant diabetic retinopathy in homozygous twins: The importance of good metabolic control
53. The influence of combined kidney-pancreas transplantation on the progression of diabetic retinopathy. A case series
54. The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial
55. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy
56. Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial
57. Progression of retinopathy after improved metabolic control in type 2 diabetic patients
58. Progression of retinopathy in insulin-treated type 2 diabetic patients
59. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
60. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
61. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38)
62. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 39)
63. A randomized trial of Sorbinil, an aldose reductase inhibitor, in diabetic retinopathy
64. The Astemizole Retinopathy Trial: Effect of astemizole on diabetic macular edema
65. High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes
66. Randomised placebo-controlled trial of human recombinant insulin-like growth factor 1 plus intensive insulin therapy in adolescents with insulin-dependent diabetes mellitus
67. Cotherapy with recombinant human insulin-like growth factor I and insulin improves glycemic control in type 1 diabetes
68. Improvement of HbA1c without increased hypoglycemia in adolescents and young adults with type 1 diabetes mellitus treated with recombinant human insulin-like growth factor I and insulin. rhIGF-1 in IDDM Study Group
69. Evidence that upregulation of serum IGF-1 concentration can trigger acceleration of diabetic retinopathy
70. Cotherapy with recombinant human IGF-I and insulin improves glycemic control in type 1 diabetes
71. Treatment of nonproliferative diabetic retinopathy with defibrotide in noninsulin-dependent diabetes mellitus: A pilot study
72. Growth hormone replacement therapy is not associated with retinal changes
73. Octreotide (somatostatin analog) treatment reduces endothelial cell dysfunction in patients with diabetes mellitus
74. The efficacy of Octreotide in the therapy of severe non-proliferative and early proliferative diabetic retinopathy: A randomized controlled study
75. Octreotide reduces vitreous haemorrhage and loss of visual acuity risk in patients with high-risk proliferative diabetic retinopathy
76. Early photocoagulation in patients with either type I or type II diabetes
77. Focal photocoagulation treatment of diabetic macular edema. Relationship of treatment effect to fluorescein angiographic and other characteristics at baseline: ETDRS report no. 19
78. One-year outcomes of panretinal photocoagulation in proliferative diabetic retinopathy
79. The National Diabetic Retinopathy Laser Treatment Audit. III. Clinical outcomes
80. Diabetic vitreopathy
81. Macular traction detachment and diabetic macular edema associated with posterior hyalodal traction
82. Diabetic Retinopathy Vitrectomy Study. Report no. 5: Early vitrectomy for severe vitreous haemorrhage in diabetic retinopathy. Four-year results of a randomized trial
83. Pars plana vitrectomy in the Early Treatment Diabetic Retinopathy Study. ETDRS report no. 17
84. Vitrectomy in the management of diabetic eye disease
85. Combined pars plana vitrectomy, lensectomy and silicon oil retinal tamponade in the initial management of complex retinal detachment associated with proliferative diabetic retinopathy
86. Long-term follow up after vitreous surgery in cases with diabetic neovascular glaucoma
87. Complications and prognosis of children with IDDM
88. Early diabetes-related complications in children and adolescents with type 1 diabetes. Implications for screening and intervention
89. Genetic heterogenity of autoimmune diabetes: Age of presentation in adults is influenced by HLADRB1 and DQB1 genotypes (UKPDS 43)
90. HLA-DR3 and DR4 and their relation to the incidence and progression of diabetic retinopathy